June 10th, 2013
Research During Fellowship: Perspectives from the Protégé and the Mentor
Stephen Archer, MD and John Ryan, MD
In the first part of this post, CardioExchange’s John Ryan writes about the research he performed during his cardiology fellowship under the mentorship of Stephen Archer. In the second part, originally delivered at the Resident Research Day at Queen’s University, at which he is Professor and Head of the Department of Medicine, Archer gives his “elevator […]
March 25th, 2013
Once Again FDA Rejects Oral Treprostinil for Pulmonary Arterial Hypertension
Larry Husten, PHD
For the second time the FDA has issued a complete response letter rejecting the new drug application (NDA) of oral treprostinil for the treatment of pulmonary arterial hypertension (PAH). The manufacturer of the drug, United Therapeutics, said in a press release that it planned to discuss the decision with the FDA. “We remain confident that oral treprostinil will play […]
NEJM Journal Watch — Recent Cardiology Articles- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?
- Are Angiographically-Derived Coronary Physiology Measurements Ready for Use in the Cath Lab?
- A Randomized Trial of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation
- An Early Look at a Novel Intranasal Loop Diuretic